Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $1.50 billion. The enterprise value is $1.06 billion.
| Market Cap | 1.50B |
| Enterprise Value | 1.06B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 139.72 million shares outstanding. The number of shares has increased by 11.18% in one year.
| Current Share Class | 139.72M |
| Shares Outstanding | 139.72M |
| Shares Change (YoY) | +11.18% |
| Shares Change (QoQ) | +2.22% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 75.70% |
| Float | 134.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.68 |
| Forward PS | 27.72 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.13.
| Current Ratio | 6.10 |
| Quick Ratio | 5.04 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.34% and return on invested capital (ROIC) is -32.86%.
| Return on Equity (ROE) | -56.34% |
| Return on Assets (ROA) | -30.14% |
| Return on Invested Capital (ROIC) | -32.86% |
| Return on Capital Employed (ROCE) | -61.66% |
| Weighted Average Cost of Capital (WACC) | 13.27% |
| Revenue Per Employee | $175,310 |
| Profits Per Employee | -$1.05M |
| Employee Count | 377 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.65% in the last 52 weeks. The beta is 1.77, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 1.77 |
| 52-Week Price Change | -24.65% |
| 50-Day Moving Average | 13.91 |
| 200-Day Moving Average | 13.40 |
| Relative Strength Index (RSI) | 30.48 |
| Average Volume (20 Days) | 4,711,235 |
Short Selling Information
The latest short interest is 49.22 million, so 35.23% of the outstanding shares have been sold short.
| Short Interest | 49.22M |
| Short Previous Month | 50.32M |
| Short % of Shares Out | 35.23% |
| Short % of Float | 36.73% |
| Short Ratio (days to cover) | 7.38 |
Income Statement
In the last 12 months, NTLA had revenue of $66.09 million and -$394.60 million in losses. Loss per share was -$3.52.
| Revenue | 66.09M |
| Gross Profit | -230.67M |
| Operating Income | -420.72M |
| Pretax Income | -394.60M |
| Net Income | -394.60M |
| EBITDA | -411.24M |
| EBIT | -420.72M |
| Loss Per Share | -$3.52 |
Balance Sheet
The company has $375.99 million in cash and $80.49 million in debt, with a net cash position of $436.76 million or $3.13 per share.
| Cash & Cash Equivalents | 375.99M |
| Total Debt | 80.49M |
| Net Cash | 436.76M |
| Net Cash Per Share | $3.13 |
| Equity (Book Value) | 620.94M |
| Book Value Per Share | 5.16 |
| Working Capital | 390.00M |
Cash Flow
In the last 12 months, operating cash flow was -$363.15 million and capital expenditures -$473,000, giving a free cash flow of -$363.63 million.
| Operating Cash Flow | -363.15M |
| Capital Expenditures | -473,000 |
| Depreciation & Amortization | 9.47M |
| Net Borrowing | n/a |
| Free Cash Flow | -363.63M |
| FCF Per Share | -$2.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | -636.56% |
| Pretax Margin | -597.04% |
| Profit Margin | n/a |
| EBITDA Margin | -622.23% |
| EBIT Margin | -636.56% |
| FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.18% |
| Shareholder Yield | -11.18% |
| Earnings Yield | -26.32% |
| FCF Yield | -24.25% |
Analyst Forecast
The average price target for NTLA is $26.17, which is 143.90% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.17 |
| Price Target Difference | 143.90% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 121.24% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of -0.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.46 |
| Piotroski F-Score | 4 |